These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9277915)

  • 21. [McArdle disease (gycogenosis type V): analysis of clinical, biological and genetic features of five French patients].
    Delmont E; Sacconi S; Berge-Lefranc JL; Aquaron R; Butori C; Desnuelle C
    Rev Neurol (Paris); 2008 Nov; 164(11):912-6. PubMed ID: 18808785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nation-wide survey on muscle glycogen storage disease (MGSDs) and comparison with our experiences in diagnosis of MGSDs].
    Fukuda T; Sugie H; Ito M; Sugie Y; Saito K; Nishino I; Shimizu T
    Rinsho Shinkeigaku; 2003 May; 43(5):243-8. PubMed ID: 12931628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Permanent muscle weakness in McArdle disease.
    Nadaj-Pakleza AA; Vincitorio CM; Laforêt P; Eymard B; Dion E; Teijeira S; Vietez I; Jeanpierre M; Navarro C; Stojkovic T
    Muscle Nerve; 2009 Sep; 40(3):350-7. PubMed ID: 19670320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glycogenosis type V (muscle phosphorylase deficiency)].
    Kono N; Itoh N
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):45-8. PubMed ID: 9589985
    [No Abstract]   [Full Text] [Related]  

  • 25. [Late diagnosis of a McArdle disease's case (type V glycogenosis)].
    Flavier S; Rolland MO; Eude M; Fédou C; Brun JF; Maire I; Mercier J; Raynaud E
    Ann Biol Clin (Paris); 2007; 65(5):550-4. PubMed ID: 17913675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [McArdle's disease. Apropos of a case].
    Yuste JR; Beloqui O; De la Peña A; Rodríguez-Rosado R; Monreal JI; Prósper F; Prieto J
    Rev Med Univ Navarra; 1998; 42(1):29-33. PubMed ID: 10420954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The case of stainless statins.
    Barth JH; Brownjohn AM; Jamieson DR
    Ann Clin Biochem; 2003 Sep; 40(Pt 5):576-7. PubMed ID: 14504000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotyping glycogen storage disease type II and type V in cattle reared in the Czech Republic.
    Cítek J; Rehout V; Vecerek L; Hájková J
    J Vet Med A Physiol Pathol Clin Med; 2007 Jun; 54(5):257-9. PubMed ID: 17523960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of CMT1 phenotypes by the independent coexisting neurogenetic disorders, McArdle disease and chromosome 5p trisomy.
    Thomas FP; Geller TJ; Hahn AF; Gutmann L; Huang XL; Wu H; Wyandt HE; Lebo RV
    Ann N Y Acad Sci; 1999 Sep; 883():472-6. PubMed ID: 10586277
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of glycogenosis type V with ketogenic diet.
    Busch V; Gempel K; Hack A; Müller K; Vorgerd M; Lochmüller H; Baumeister FA
    Ann Neurol; 2005 Aug; 58(2):341. PubMed ID: 16049943
    [No Abstract]   [Full Text] [Related]  

  • 31. Brief summary of a patient's case in hope that it might elicit information about similar cases from readers.
    Lessell S
    J Neuroophthalmol; 2000 Dec; 20(4):293. PubMed ID: 11130763
    [No Abstract]   [Full Text] [Related]  

  • 32. Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency.
    Schroers A; Kley RA; Stachon A; Horvath R; Lochmüller H; Zange J; Vorgerd M
    Neurology; 2006 Jan; 66(2):285-6. PubMed ID: 16434679
    [No Abstract]   [Full Text] [Related]  

  • 33. Worsening myopathy associated with ezetimibe in a patient with McArdle disease.
    Perez-Calvo J; Civeira-Murillo F; Cabello A
    QJM; 2005 Jun; 98(6):461-2. PubMed ID: 15897216
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined liver-kidney transplantation in glycogen storage disease Ia: a case beyond the guidelines.
    Belingheri M; Ghio L; Sala A; Menni F; Trespidi L; Ferraresso M; Berardinelli L; Rossi G; Edefonti A; Parini R
    Liver Transpl; 2007 May; 13(5):762-4. PubMed ID: 17457869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Type VII glycogen storage disease].
    Nakajima H; Hamaguchi T; Yamasaki T; Noguchi T; Tarui S
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):51-5. PubMed ID: 9589987
    [No Abstract]   [Full Text] [Related]  

  • 36. [An unusual type of hemolysis in Tarui disease in two families originated in the county of Vasterbotten].
    Rudolphi O; Brattsand G; Waldenström A; Nilsson AL; Ronquist G
    Lakartidningen; 2006 Mar 1-7; 103(9):657-60. PubMed ID: 16583542
    [No Abstract]   [Full Text] [Related]  

  • 37. Double trouble (McArdle's disease and myasthenia gravis): how can exercise help?
    Lucia A; Maté-Muñoz JL; Pérez M; Foster C; Gutiérrez-Rivas E; Arenas J
    Muscle Nerve; 2007 Jan; 35(1):125-8. PubMed ID: 16967472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myopathy associated with statin therapy.
    Hilton-Jones D
    Neuromuscul Disord; 2008 Jan; 18(1):97-8. PubMed ID: 17892936
    [No Abstract]   [Full Text] [Related]  

  • 39. Fueling around with glycogen: the implications of muscle phosphorylase b kinase deficiency.
    Haller RG
    Neurology; 2008 May; 70(20):1872-3. PubMed ID: 18474841
    [No Abstract]   [Full Text] [Related]  

  • 40. [Successful treatment with infliximab of a patient with refractory sarcoidosis].
    Fouchier SM; Möller GM; Van Santen-Hoeufft M; Faber CG; Smeenk FW; Drent M
    Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2446-50. PubMed ID: 15626311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.